Search

everythinglearnresearchcommunity

for

Search:↓

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Some women with common hair loss may develop permanent hair loss.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Small white dots on the scalp seen with a dermoscope correspond to sweat ducts and vary with different hair disorders.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

A scale was made to measure hair loss severity in African American women.

Recognizing specific features of African-American hair can help diagnose hair loss conditions.

Elastin staining helps assess late-stage scarring alopecia but is not definitive, and clinical diagnosis is still crucial.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Hair loss in black women needs more research, early intervention, and community education.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.